Solutia

Pomerantz is investigating claims on behalf of investors of Solutia Inc. (“Solutia” or the “Company”) (NASDAQ: SOA) (ISIN: US8343765017) concerning the proposed acquisition of Solutia by Eastman Chemical Company in a cash and stock transaction valued at approximately $4.7 billion.

The investigation concerns whether the Solutia directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under the terms of the agreement, Solutia shareholders will receive $22.00 in cash and 0.12 shares of Eastman common stock for each share of Solutia common stock. However, at least one analyst has set a target price of $28.00 per share. Additionally, Solutia shareholders are not benefiting from $100 million in synergies resulting from the proposed transaction.

Solutia shareholders seeking more information about this acquisition are advised to contact Gustavo Bruckner, Esq. at gfbruckner [at] pomlaw [dot] com or 212-661-1100 or toll free at 888-476-6529, ext. 302. Shareholders may also contact Rebecca Jarmon at rjarmon [at] pomlaw [dot] com or 212-661-1100 or 888-476-6529, ext. 314.